nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—Cognitive disorder—Methylprednisolone—psoriatic arthritis	0.0161	0.0161	CcSEcCtD
Miglustat—Cognitive disorder—Dexamethasone—psoriatic arthritis	0.0146	0.0146	CcSEcCtD
Miglustat—Cognitive disorder—Betamethasone—psoriatic arthritis	0.0146	0.0146	CcSEcCtD
Miglustat—Menstruation irregular—Prednisolone—psoriatic arthritis	0.0137	0.0137	CcSEcCtD
Miglustat—Weight decreased—Auranofin—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Miglustat—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.013	0.013	CcSEcCtD
Miglustat—Cognitive disorder—Prednisone—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Miglustat—Menstruation irregular—Triamcinolone—psoriatic arthritis	0.0126	0.0126	CcSEcCtD
Miglustat—Menstruation irregular—Methylprednisolone—psoriatic arthritis	0.0126	0.0126	CcSEcCtD
Miglustat—Visual impairment—Auranofin—psoriatic arthritis	0.0115	0.0115	CcSEcCtD
Miglustat—Menstruation irregular—Betamethasone—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Miglustat—Menstruation irregular—Dexamethasone—psoriatic arthritis	0.0114	0.0114	CcSEcCtD
Miglustat—Eye disorder—Auranofin—psoriatic arthritis	0.0112	0.0112	CcSEcCtD
Miglustat—Cognitive disorder—Methotrexate—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Miglustat—Flatulence—Auranofin—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Miglustat—Neuritis—Prednisolone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Miglustat—Menstruation irregular—Prednisone—psoriatic arthritis	0.00994	0.00994	CcSEcCtD
Miglustat—Neuritis—Triamcinolone—psoriatic arthritis	0.00933	0.00933	CcSEcCtD
Miglustat—Neuritis—Methylprednisolone—psoriatic arthritis	0.00931	0.00931	CcSEcCtD
Miglustat—Appetite absent—Methotrexate—psoriatic arthritis	0.00925	0.00925	CcSEcCtD
Miglustat—Tingling sensation—Methylprednisolone—psoriatic arthritis	0.00865	0.00865	CcSEcCtD
Miglustat—Neuritis—Dexamethasone—psoriatic arthritis	0.00847	0.00847	CcSEcCtD
Miglustat—Neuritis—Betamethasone—psoriatic arthritis	0.00847	0.00847	CcSEcCtD
Miglustat—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0083	0.0083	CcSEcCtD
Miglustat—Anorexia—Auranofin—psoriatic arthritis	0.00808	0.00808	CcSEcCtD
Miglustat—Tingling sensation—Dexamethasone—psoriatic arthritis	0.00786	0.00786	CcSEcCtD
Miglustat—Tingling sensation—Betamethasone—psoriatic arthritis	0.00786	0.00786	CcSEcCtD
Miglustat—Dyspepsia—Auranofin—psoriatic arthritis	0.00746	0.00746	CcSEcCtD
Miglustat—Neuritis—Prednisone—psoriatic arthritis	0.00737	0.00737	CcSEcCtD
Miglustat—Decreased appetite—Auranofin—psoriatic arthritis	0.00737	0.00737	CcSEcCtD
Miglustat—Constipation—Auranofin—psoriatic arthritis	0.00725	0.00725	CcSEcCtD
Miglustat—Neuropathy—Prednisolone—psoriatic arthritis	0.00711	0.00711	CcSEcCtD
Miglustat—Memory impairment—Prednisone—psoriatic arthritis	0.00701	0.00701	CcSEcCtD
Miglustat—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00693	0.00693	CcSEcCtD
Miglustat—Abdominal pain—Auranofin—psoriatic arthritis	0.0067	0.0067	CcSEcCtD
Miglustat—Neuropathy—Triamcinolone—psoriatic arthritis	0.00654	0.00654	CcSEcCtD
Miglustat—Neuropathy—Methylprednisolone—psoriatic arthritis	0.00653	0.00653	CcSEcCtD
Miglustat—Neuropathy—Dexamethasone—psoriatic arthritis	0.00594	0.00594	CcSEcCtD
Miglustat—Neuropathy—Betamethasone—psoriatic arthritis	0.00594	0.00594	CcSEcCtD
Miglustat—Visual disturbance—Prednisolone—psoriatic arthritis	0.0058	0.0058	CcSEcCtD
Miglustat—Diarrhoea—Auranofin—psoriatic arthritis	0.0058	0.0058	CcSEcCtD
Miglustat—Vomiting—Auranofin—psoriatic arthritis	0.00539	0.00539	CcSEcCtD
Miglustat—Amnesia—Methylprednisolone—psoriatic arthritis	0.00537	0.00537	CcSEcCtD
Miglustat—Neuropathy—Prednisone—psoriatic arthritis	0.00517	0.00517	CcSEcCtD
Miglustat—Nausea—Auranofin—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Miglustat—Muscular weakness—Prednisolone—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Miglustat—Visual disturbance—Betamethasone—psoriatic arthritis	0.00484	0.00484	CcSEcCtD
Miglustat—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00484	0.00484	CcSEcCtD
Miglustat—Abdominal distension—Prednisolone—psoriatic arthritis	0.00479	0.00479	CcSEcCtD
Miglustat—Migraine—Dexamethasone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Miglustat—Migraine—Betamethasone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Miglustat—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Miglustat—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Miglustat—Abdominal distension—Triamcinolone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Miglustat—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Miglustat—Amnesia—Prednisone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Miglustat—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Miglustat—Muscular weakness—Betamethasone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Miglustat—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Miglustat—Haemoglobin—Prednisolone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Miglustat—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Miglustat—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Miglustat—Haemorrhage—Prednisolone—psoriatic arthritis	0.0038	0.0038	CcSEcCtD
Miglustat—Visual impairment—Prednisolone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Miglustat—Weight decreased—Betamethasone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Miglustat—Weight decreased—Dexamethasone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Miglustat—Muscular weakness—Prednisone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Miglustat—Visual disturbance—Methotrexate—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Miglustat—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Miglustat—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Miglustat—Haemorrhage—Triamcinolone—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Miglustat—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00349	0.00349	CcSEcCtD
Miglustat—Abdominal distension—Prednisone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Miglustat—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Miglustat—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Miglustat—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Miglustat—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Miglustat—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Miglustat—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Miglustat—Haemoglobin—Betamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Miglustat—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Miglustat—Haemorrhage—Betamethasone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Miglustat—Ataxia—Methotrexate—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Miglustat—Weight decreased—Prednisone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Miglustat—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Miglustat—Depression—Prednisone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Miglustat—Visual impairment—Betamethasone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Miglustat—Visual impairment—Dexamethasone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Miglustat—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Miglustat—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Miglustat—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Miglustat—Malaise—Prednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Miglustat—Vertigo—Prednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Miglustat—Eye disorder—Betamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Miglustat—Eye disorder—Dexamethasone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Miglustat—Back pain—Triamcinolone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Miglustat—Convulsion—Prednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Miglustat—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Miglustat—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00282	0.00282	CcSEcCtD
Miglustat—Discomfort—Prednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Miglustat—Haemoglobin—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Miglustat—Haemorrhage—Prednisone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Miglustat—Malaise—Triamcinolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Miglustat—Malaise—Methylprednisolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Miglustat—Vertigo—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Miglustat—Vertigo—Methylprednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Miglustat—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Miglustat—Convulsion—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Miglustat—Convulsion—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Miglustat—Eye disorder—Prednisone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Miglustat—Depression—Methotrexate—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Miglustat—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Miglustat—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Miglustat—Discomfort—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Miglustat—Discomfort—Methylprednisolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Miglustat—Dry mouth—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Miglustat—Malaise—Dexamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Miglustat—Malaise—Betamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Miglustat—Vertigo—Betamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Miglustat—Vertigo—Dexamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Miglustat—Insomnia—Prednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Miglustat—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Miglustat—Paraesthesia—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Miglustat—Mental disorder—Prednisone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Miglustat—Malnutrition—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Miglustat—Convulsion—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Miglustat—Convulsion—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Miglustat—Discomfort—Betamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Miglustat—Discomfort—Dexamethasone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Miglustat—Haemoglobin—Methotrexate—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Miglustat—Pain—Prednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Miglustat—Haemorrhage—Methotrexate—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Miglustat—Insomnia—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Miglustat—Insomnia—Methylprednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Miglustat—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Miglustat—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Miglustat—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Miglustat—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Miglustat—Visual impairment—Methotrexate—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Miglustat—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Miglustat—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Miglustat—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Miglustat—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Miglustat—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Miglustat—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Miglustat—Malaise—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Miglustat—Vertigo—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Miglustat—Eye disorder—Methotrexate—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Miglustat—Anorexia—Dexamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Miglustat—Anorexia—Betamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Miglustat—Fatigue—Triamcinolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Miglustat—Fatigue—Methylprednisolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Miglustat—Pain—Triamcinolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Miglustat—Convulsion—Prednisone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Miglustat—Chills—Methotrexate—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Miglustat—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Miglustat—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Miglustat—Insomnia—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Miglustat—Insomnia—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Miglustat—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Miglustat—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Miglustat—Paraesthesia—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Miglustat—Discomfort—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Miglustat—Mental disorder—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Miglustat—Malnutrition—Methotrexate—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Miglustat—Dyspepsia—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Miglustat—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Miglustat—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Miglustat—Decreased appetite—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Miglustat—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Miglustat—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Miglustat—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Miglustat—Back pain—Methotrexate—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Miglustat—Fatigue—Betamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Miglustat—Fatigue—Dexamethasone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Miglustat—Pain—Dexamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Miglustat—Pain—Betamethasone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Miglustat—Nervous system disorder—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Miglustat—Anorexia—Prednisone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Miglustat—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Miglustat—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Miglustat—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Miglustat—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Miglustat—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Miglustat—Malaise—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Miglustat—Vertigo—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Miglustat—Dizziness—Prednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Miglustat—Asthenia—Triamcinolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Miglustat—Abdominal pain—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Miglustat—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Miglustat—Asthenia—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Miglustat—Insomnia—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Miglustat—Paraesthesia—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Miglustat—Convulsion—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Miglustat—Dyspepsia—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Miglustat—Decreased appetite—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Miglustat—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Miglustat—Fatigue—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Miglustat—Headache—Prednisolone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Miglustat—Discomfort—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Miglustat—Constipation—Prednisone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Miglustat—Dizziness—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Miglustat—Dizziness—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Miglustat—Feeling abnormal—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Miglustat—Asthenia—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Miglustat—Asthenia—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Miglustat—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Miglustat—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Miglustat—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Miglustat—Nausea—Prednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Miglustat—Vomiting—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Miglustat—Vomiting—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Miglustat—Anorexia—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Miglustat—Headache—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Miglustat—Headache—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Miglustat—Abdominal pain—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Miglustat—Diarrhoea—Betamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Miglustat—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Miglustat—Dizziness—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Miglustat—Dizziness—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Miglustat—Insomnia—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Miglustat—Nausea—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Miglustat—Paraesthesia—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Miglustat—Nausea—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Miglustat—Dyspepsia—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Miglustat—Vomiting—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Miglustat—Vomiting—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Miglustat—Decreased appetite—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Miglustat—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Miglustat—Fatigue—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Miglustat—Headache—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Miglustat—Headache—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Miglustat—Asthenia—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Miglustat—Pain—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Miglustat—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Miglustat—Diarrhoea—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Miglustat—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Miglustat—Nausea—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Miglustat—Nausea—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Miglustat—Dizziness—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Miglustat—Abdominal pain—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Miglustat—Vomiting—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Miglustat—Headache—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Miglustat—Asthenia—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Miglustat—Nausea—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Miglustat—Diarrhoea—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Miglustat—Dizziness—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Miglustat—Vomiting—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Miglustat—Headache—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Miglustat—Nausea—Methotrexate—psoriatic arthritis	0.000975	0.000975	CcSEcCtD
